Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Leveljump Healthcare Corp V.JUMP

Alternate Symbol(s):  JMPHF

LevelJump Healthcare Corp. is a Canada-based company. The Company’s principal business activity is providing radiology services both by providing direct patient images and by providing Teleradiology services. Teleradiology is the process of providing remote off site reading of radiology scans such as computed tomography (CT), magnetic resonance imaging (MRI), ultrasound (US), and X-ray... see more

TSXV:JUMP - Post Discussion

Leveljump Healthcare Corp > Acquires Additional 8.31% of Real Time Medical
View:
Post by Betteryear2 on Feb 15, 2022 1:11pm

Acquires Additional 8.31% of Real Time Medical

Toronto, Ontario--(Newsfile Corp. - February 15, 2022) - Leveljump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) ("Leveljump" or the "Company"), a Canadian leader in B2B telehealth solutions, is pleased to announce that it has closed its previously announced acquisition of an additional interest in Real Time Medical Inc. ("RTM"), a private Ontario company, in exchange for 1,420,961 units (a "Unit") of Leveljump. Each Unit will be issued at a price of $0.65 per Unit with each Unit being comprised of five (5) Leveljump common shares at a deemed price of $0.12 per share and one (1) share purchase warrant of Leveljump, each warrant entitling the holder to acquire one additional common share of Leveljump at a price of $0.35 per common share on or before December 31, 2023.

Leveljump now owns a 25.21% interest in RTM.

The RTM purchase has received the consent of the TSX Venture Exchange (the "Exchange") and the consent of the board of directors of RTM. For further information regarding the Company's interest in RTM, please see the Company's news release dated November 25, 2021.

All securities issued will be subject to a hold period of four months and one day pursuant to applicable securities laws.

In addition to the purchase of the RTM shares, the Company has agreed to purchase from one of the vendors a promissory note, due from RTM to the holder, with a face amount of $100,000 and accrued interest of approximately $30,000. The Company has paid a $50,000 deposit to the note holder upon closing of the purchase of the RTM shares and the balance of the note principal and accrued interest on or before June 30, 2022.

About Leveljump Healthcare

Leveljump Healthcare Corp., (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) is a healthcare company with a focus on profitable telehealth solutions as well as primary care services in radiology. The Company's subsidiary, CTS, provides off-site radiology readings for hospital emergency rooms and is a leader in the teleradiology space in Ontario. As part of our growth strategy, we are acquiring healthcare companies that have strong revenue and cash flow, with room for organic growth.


https://www.newsfilecorp.com/release/113894

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities